v3.26.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
Common Stock [Member]
At Market Offering [Member]
Common Stock [Member]
Direct Offering [Member]
Common Stock [Member]
Public Offering
Common Stock [Member]
Additional Paid-in Capital [Member]
At Market Offering [Member]
Additional Paid-in Capital [Member]
Direct Offering [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
At Market Offering [Member]
Direct Offering [Member]
Total
Beginning Balance at Sep. 30, 2023       $ 1     $ 307,398,305 $ (302,447,147) $ (78,747)     $ 4,872,412
Beginning Balance (in shares) at Sep. 30, 2023       911                
Increase (Decrease) in Stockholders' Equity                        
Common stock and pre-funded warrants issued in public offering, net of offering costs       $ 1     10,525,062         10,525,063
Common stock and pre-funded warrants issued in public offering, net of offering costs (in shares)     967                  
Stock based compensation expense             572,293         572,293
Deemed dividend - warrant repricing             233,087 (233,087)        
Common stock issued in ATM, net of offering costs         $ 64,397 $ 161       $ 64,397 $ 161  
Common stock issued in ATM, net of offering costs (in shares) 12 215                    
Share issued upon restricted stock vesting (in shares)       19                
Share issued upon warrant exercises       $ 12     4,928         4,940
Share issued upon warrant exercises (in shares)       11,501                
Adjustment for reverse split (in shares)       113                
Common stock issued, Spindle earnout             17,125         17,125
Common stock issued, Spindle earnout (in shares)       17                
Net loss               (6,992,521) (95,785)     (7,088,306)
Ending Balance at Sep. 30, 2024       $ 14     318,815,358 (309,672,755) (174,532)     $ 8,968,085
Ending Balance (in shares) at Sep. 30, 2024       13,755               13,755
Increase (Decrease) in Stockholders' Equity                        
Exercise of warrants, cashlessly       $ 28     (28)          
Exercise of warrants, cashlessly (in shares)       27,895                
Stock based compensation expense             28,973         $ 28,973
Deemed dividend - warrant repricing             14,907,223 (14,907,223)        
Net loss               (2,639,412) (29,301)     (2,668,713)
Ending Balance at Dec. 31, 2024       $ 72     339,972,796 (327,219,390) (203,833)     12,549,645
Ending Balance (in shares) at Dec. 31, 2024       72,155                
Beginning Balance at Sep. 30, 2024       $ 14     318,815,358 (309,672,755) (174,532)     $ 8,968,085
Beginning Balance (in shares) at Sep. 30, 2024       13,755               13,755
Increase (Decrease) in Stockholders' Equity                        
Net loss                       $ (6,004,833)
Ending Balance at Mar. 31, 2025       $ 422     364,902,558 (354,442,994) (235,778)     10,224,208
Ending Balance (in shares) at Mar. 31, 2025       422,095                
Beginning Balance at Sep. 30, 2024       $ 14     318,815,358 (309,672,755) (174,532)     $ 8,968,085
Beginning Balance (in shares) at Sep. 30, 2024       13,755               13,755
Increase (Decrease) in Stockholders' Equity                        
Exercise of warrants, cashlessly       $ 1,314     (1,314)          
Exercise of warrants, cashlessly (in shares)       1,314,112                
Stock based compensation expense             (102,021)         $ (102,021)
Deemed dividend - warrant repricing             54,326,896 (54,326,896)        
Common stock issued in ATM, net of offering costs   $ 27       $ 5,712,673         $ 5,712,700  
Common stock issued in ATM, net of offering costs (in shares)   27,083                    
Share issued upon warrant exercises       $ 229     2,507,904         2,508,133
Share issued upon warrant exercises (in shares)       228,947                
Adjustment for reverse split       $ 79     (79)          
Adjustment for reverse split (in shares)       78,704                
Net loss               (15,160,724) (188,522)     (15,349,246)
Ending Balance at Sep. 30, 2025       $ 1,663     381,463,459 (379,160,375) (363,054)     $ 1,941,693
Ending Balance (in shares) at Sep. 30, 2025       1,662,601               1,662,601
Beginning Balance at Dec. 31, 2024       $ 72     339,972,796 (327,219,390) (203,833)     $ 12,549,645
Beginning Balance (in shares) at Dec. 31, 2024       72,155                
Increase (Decrease) in Stockholders' Equity                        
Exercise of warrants, cashlessly       $ 315     (315)          
Exercise of warrants, cashlessly (in shares)       314,845                
Stock based compensation expense             26,511         26,511
Deemed dividend - warrant repricing             23,919,429 (23,919,429)        
Adjustment for reverse split       $ 5     (5)          
Adjustment for reverse split (in shares)       5,092                
Net loss               (3,304,175) (31,945)     (3,336,120)
Ending Balance at Mar. 31, 2025       $ 422     364,902,558 (354,442,994) (235,778)     10,224,208
Ending Balance (in shares) at Mar. 31, 2025       422,095                
Beginning Balance at Sep. 30, 2025       $ 1,663     381,463,459 (379,160,375) (363,054)     $ 1,941,693
Beginning Balance (in shares) at Sep. 30, 2025       1,662,601               1,662,601
Increase (Decrease) in Stockholders' Equity                        
Exercise of warrants, cashlessly       $ 407     (407)          
Exercise of warrants, cashlessly (in shares)       406,730                
Stock based compensation expense             633,120         $ 633,120
Deemed dividend - warrant repricing             32,827 (32,827)        
Net loss               (18,593,563) (12,619)     (18,606,182)
Ending Balance at Dec. 31, 2025       $ 4,774     416,617,812 (397,786,765) (375,673)     18,460,148
Ending Balance (in shares) at Dec. 31, 2025       4,772,271                
Beginning Balance at Sep. 30, 2025       $ 1,663     381,463,459 (379,160,375) (363,054)     $ 1,941,693
Beginning Balance (in shares) at Sep. 30, 2025       1,662,601               1,662,601
Increase (Decrease) in Stockholders' Equity                        
Common stock issued in ATM, net of offering costs (in shares)                   10,759    
Net loss                       $ (25,271,341)
Ending Balance at Mar. 31, 2026       $ 5,669     416,951,861 (404,451,992) (375,605)     12,129,933
Ending Balance (in shares) at Mar. 31, 2026       5,667,469                
Beginning Balance at Dec. 31, 2025       $ 4,774     416,617,812 (397,786,765) (375,673)     18,460,148
Beginning Balance (in shares) at Dec. 31, 2025       4,772,271                
Increase (Decrease) in Stockholders' Equity                        
Exercise of warrants, cashlessly       $ 695     (695)          
Exercise of warrants, cashlessly (in shares)       695,270                
Stock based compensation expense             334,944         334,944
Common stock issued in ATM, net of offering costs (in shares)                   10,759    
Net loss               (6,665,227) 68     (6,665,159)
Ending Balance at Mar. 31, 2026       $ 5,669     $ 416,951,861 $ (404,451,992) $ (375,605)     $ 12,129,933
Ending Balance (in shares) at Mar. 31, 2026       5,667,469